BAYER AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.50 EUR | +1.25% |
|
+1.80% | -42.02% |
| Dec. 05 | Bayer competitor Corteva wants to significantly expand its soybean business in Brazil | DP |
| Dec. 03 | BAYER AG : JP Morgan reaffirms its Neutral rating | ZD |
Chart calendar Bayer AG
e82a7b49aa47b82f83d4599fe2b.ehofT1Tf373wel9VmpXd6Bs8CVxR-dDKSXgZVnPVtGo.AkhvBS3pkY3dMRYK4KTkrXlFeBQmkbqSJjt2IjH48l8rciwIHL6Fy5UYaw~3cd15e285a6bc98d61a0bc609bcb8507
Upcoming events on Bayer AG
Past events on Bayer AG
| 2024-12-04 | Berenberg European Conference |
| 2024-12-03 | Citi Global Healthcare Conference |
| 2024-11-20 | Jefferies London Healthcare Conference |
| 2024-11-18 | Banco Sabadell European Investor Seminar |
| 2024-11-17 | Kepler Cheuvreux Global Agriculture Forum |
| 2024-11-12 | UBS European Conference |
| 2024-11-12 | Morgan Stanley, Global Ag & Chemicals Conference |
| 2024-11-12 08:00 am | Q3 2024 Earnings Call |
| 2024-11-12 01:30 am | Q3 2024 Earnings Release |
| 2024-09-25 | Barclays DIR Conference |
| 2024-09-23 | Berenberg & Goldman Sachs German Corporate Conference |
| 2024-09-18 | BofA Global Healthcare Conference |
| 2024-09-12 | Jefferies Healthcare Back To School C-Suite Fireside Series |
| 2024-09-12 | BofA Ag Bus Trip |
| 2024-09-04 | Morgan Stanley Global Healthcare Conference |
| 2024-09-03 04:30 pm | Barclays Global Consumer Staples Conference |
| 2024-09-02 06:00 am | Phase III Study FINEARTS-HF Update Call |
| 2024-08-06 08:00 am | Q2 2024 Earnings Call |
| 2024-08-06 01:30 am | Q2 2024 Earnings Release |
| 2024-05-18 12:30 pm | American College of Obstetricians and Gynecologists Clinical & Scientific Meeting - E-Poster #IP05-C |
Past dividends on Bayer AG
| 2024-04-28 | Annual 0.11 EUR |
| 2023-05-01 | Annual 2.4 EUR |
| 2022-05-01 | Annual 2 EUR |
| 2021-04-27 | Annual 2 EUR |
| 2020-04-28 | Annual 2.8 EUR |
| 2019-04-28 | Annual 2.8 EUR |
| 2018-05-27 | Annual 2.8 EUR |
| 2017-04-30 | Annual 2.7 EUR |
| 2016-05-01 | Annual 2.5 EUR |
| 2015-05-27 | 2.25 EUR |
| 2014-04-29 | Annual 2.1 EUR |
| 2013-04-28 | Annual 1.9 EUR |
| 2012-04-29 | Annual 1.65 EUR |
| 2011-05-01 | Annual 1.5 EUR |
| 2010-05-02 | Annual 1.4 EUR |
| 2009-05-12 | Annual 1.4 EUR |
| 2008-04-27 | Annual 1.35 EUR |
| 2007-04-29 | Annual 1 EUR |
| 2006-05-01 | Annual 0.95 EUR |
| 2005-05-01 | Annual 0.55 EUR |
Annual results
| Fiscal Period | december | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 44 081 43 294 1.82% | 50 739 50 664 0.15% | 47 637 47 587 0.1% | 46 402 | 46 579 | 47 409 |
|
EBITDA Million EUR | Released Forecast Spread | 11 179 11 149 0.27% | 13 513 13 377 1.02% | 11 706 11 031 6.12% | 10 152 | 9 672 | 10 092 |
|
EBIT Million EUR | Released Forecast Spread | 7 295 7 420 -1.68% | 9 257 8 940 3.55% | 7 589 7 381 2.82% | 6 277 | 5 893 | 6 206 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 2 046 1 237 65.4% | 4 670 5 985 -21.97% | -1 621 -1 358 -19.36% | -427 | 2 779 | 3 306 |
|
Net income Million EUR | Released Forecast Spread | 1 000 671 49.02% | 4 150 4 435 -6.43% | -2 941 -1 998 -47.23% | -25,9 | 2 334 | 2 857 |
|
EPS EUR | Released Forecast Spread | 1,02 0,64 59.65% | 4,22 4,48 -5.85% | -2,99 -3,02 0.95% | -0,03 | 2,37 | 2,91 |
| Announcement Date | 01/03/22 | 28/02/23 | 05/03/24 | - |
Quarterly results
| Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2024 S2 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 14 389 14 585 -1.34% | 11 044 11 847 -6.78% | 10 342 10 448 -1.01% | 11 862 11 731 1.12% | 13 765 14 086 -2.28% | 11 144 10 913 2.11% | 9 968 10 234 -2.6% | 11 353 | 21 112 | ||||
|
EBITDA Million EUR | Released Forecast Spread | 4 471 4 650 -3.85% | 2 527 2 694 -6.19% | 1 685 1 801 -6.46% | 3 023 2 276 32.83% | 4 412 4 242 4% | 2 111 2 126 -0.69% | 1 251 1 370 -8.67% | 3 130 | 3 474 | 4 197 | 1 939 | 1 292 | 2 215 |
|
EBIT Million EUR | Released Forecast Spread | 3 404 3 210 6.03% | 1 534 1 312 16.9% | 709 958 -26.01% | 1 942 1 849 5.02% | 3 299 2 733 20.7% | 1 015 1 173 -13.48% | 267 633 -57.83% | 1 862 | |||||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 2 606 2 569 1.46% | -1 574 234 -772.65% | -4 297 680 -731.91% | 1 644 673 144.28% | |||||||||
|
Net income Million EUR | Released Forecast Spread | 2 178 1 872 16.34% | -1 887 | -4 569 393 -1262.9% | 1 337 584 128.86% | 2 000 1 438 39.12% | -34,0 77,7 -143.77% | -4 183 -284 -1370.52% | 4 125 | |||||
|
EPS EUR | Released Forecast Spread | 2,22 1,90 16.6% | -1,92 | -4,66 0,41 -1226.26% | 1,36 0,59 128.58% | 2,04 1,46 39.37% | -0,03 0,08 -138.25% | -4,26 -0,29 -1371.4% | 4,19 | |||||
| Announcement Date | 11/05/23 | 08/08/23 | 08/11/23 | 05/03/24 | 13/05/24 | 06/08/24 | 12/11/24 | - | - | - | - | - | - |
More events
Past sector events for Bayer AG
| 2024-12-04 02:06 am | CALIWAY BIOPHARMACEUTICALS CO., LTD.: November 2024 Sales and Revenue Release |
| 2024-11-28 | DOTTIKON ES HOLDING AG: Q2 2025 Earnings Release |
| 2024-11-15 01:38 am | BAVARIAN NORDIC A/S: Q3 2024 Earnings Release |
| 2024-11-14 11:01 pm | CSPC PHARMACEUTICAL GROUP LTD.: Q3 2024 Earnings Release |
| 2024-11-14 09:03 am | GUFIC BIOSCIENCES LIMITED: Q2 2025 Earnings Release |
| 2024-11-14 07:00 am | OCULAR THERAPEUTIX, INC.: Q3 2024 Earnings Release |
| 2024-11-14 02:49 am | IPCA LABORATORIES LIMITED: Q2 2025 Earnings Release |
| 2024-11-14 01:30 am | DERMAPHARM HOLDING SE: Q3 2024 Earnings Release |
| 2024-11-14 01:30 am | ALK-ABELLÓ A/S: Q3 2024 Earnings Release |
| 2024-11-13 | DONGKOOK PHARMACEUTICAL CO., LTD.: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BAYN Stock
- Calendar Bayer AG